Literature DB >> 31444693

The modulation of the TREM-1/PGLYRP1/MMP-8 axis in peri-implant diseases.

Mayla K S Teixeira1, Ronaldo Lira-Junior2,3, Eduardo José Veras Lourenço1, Daniel Moraes Telles1, Elisabeth A Boström3, Carlos Marcelo Figueredo4,5, Nagihan Bostanci3.   

Abstract

OBJECTIVES: The aim of this study is to investigate the expression of sTREM-1 and its ligand PGLYRP1, as well as the expression of MMP-8 and its inhibitor TIMP-1, in peri-implant diseases. As a secondary aim, we analyzed the influence of the concomitant existence of periodontitis in the expression of these biomarkers.
MATERIALS AND METHODS: This study included 77 patients (29 males and 48 females; mean age 55.0 ± 11.5), 18 having gingivitis, 16 having periodontitis, 20 having mucositis, and 23 having peri-implantitis. Patients were clinically examined, and unstimulated whole saliva was collected. sTREM-1, PGLYRP1, MMP-8, TIMP-1, and MMP-8/TIMP1 ratio were determined by ELISA.
RESULTS: The periodontitis group presented higher probing depth (PD) mean, and higher clinical attachment loss, compared with the other groups. The peri-implantitis group presented higher PD mean in implants compared to the mucositis group. Patients with PD ≥ 6 mm showed significantly higher levels of PGLYRP1, MMP-8, and MMP-8/TIMP-1 ratio than patients with PD < 6 mm. When all four markers were assessed, there were no significant differences between mucositis and peri-implantitis groups. Concomitant periodontitis resulted in higher significant levels of MMP-8 in patients with peri-implant disease.
CONCLUSION: We did not observe significant differences in the levels of the sTREM-1/PGLYRP1/MMP-8 axis between patients with periodontal and peri-implant diseases, suggesting that these markers are also involved in the inflammatory process around implants. Besides, the presence of periodontitis may affect the levels of MMP-8 in patients with peri-implant disease. CLINICAL RELEVANCE: The sTREM-1/PGLYRP1/MMP-8 axis could be useful as potent markers in periodontal and peri-implant diseases.

Entities:  

Keywords:  MMP-8; Mucositis; PGLYRP1; Peri-implantitis; Periodontitis; TREM-1

Mesh:

Substances:

Year:  2019        PMID: 31444693     DOI: 10.1007/s00784-019-03047-z

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  5 in total

1.  Evaluation of adipokines and inflammatory mediator expression levels in patients with periodontitis and peri-implantitis: a cross-sectional study.

Authors:  Sila Cagri Isler; Fatma Soysal; Erkan Ozcan; N Isıl Saygun; F Berrin Unsal; Emre Baris; Rahsan Ilikci
Journal:  Clin Oral Investig       Date:  2020-11-12       Impact factor: 3.573

2.  Evaluation of "soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), interleukin-1β, and matrix metalloproteinase-8" as a short panel of salivary biomarkers in patients with and without stage III/IV periodontitis and type 2 diabetes mellitus.

Authors:  Saranya Balaji; Priyanka K Cholan; Dhayanand John Victor
Journal:  J Oral Biol Craniofac Res       Date:  2021-10-08

3.  Removal of nonimpacted third molars alters the periodontal condition of their neighbors clinically, immunologically, and microbiologically.

Authors:  Yi Tian; Lijuan Sun; Honglei Qu; Yang Yang; Faming Chen
Journal:  Int J Oral Sci       Date:  2021-02-07       Impact factor: 6.344

4.  Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues.

Authors:  Luciene Cristina Figueiredo; Bruno Bueno-Silva; Cristiana Fernandes Plutarco Nogueira; Leonardo Carneiro Valadares; Katia Marina Morilla Garcia; Givelton Coimbra da Luz Filho; Luciano Milanello; Felipe Machado Esteves; Jamil Awad Shibli; Tamires Szeremeske Miranda
Journal:  Int J Environ Res Public Health       Date:  2020-12-06       Impact factor: 3.390

5.  Peri-Implant Surgical Treatment Downregulates the Expression of sTREM-1 and MMP-8 in Patients with Peri-Implantitis: A Prospective Study.

Authors:  Glaucia Schuindt Teixeira Neves; Gayathiri Elangovan; Mayla Kezy Silva Teixeira; João Martins de Mello-Neto; Santosh Kumar Tadakamadla; Eduardo José Veras Lourenço; Daniel Moraes Telles; Carlos Marcelo Figueredo
Journal:  Int J Environ Res Public Health       Date:  2022-03-18       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.